← SynDRA
2VL
SynDRA canonical compound SYN1216525 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | BTK |
| Mechanism of action | Bruton's tyrosine kinase (BTK) inhibitor |
All known targets
Mechanisms of action (all sources)
- Bruton's tyrosine kinase (BTK) inhibitor
Cross-references
Synonyms
- CPD2
- GDC-0834
- GDC-0837
- GDC0834
- GDC 0834
- UNII-FM7JG3L4SR
- FM7JG3L4SR
- CHEMBL2057915
- N-{3-[6-({4-[(2r)-1,4-Dimethyl-3-Oxopiperazin-2-Yl]phenyl}amino)-4-Methyl-5-Oxo-4,5-Dihydropyrazin-2-Yl]-2-Methylphenyl}-4,5,6,7-Tetrahydro-1-Benzothiophene-2-Carboxamide
- CDOOFZZILLRUQH-GDLZYMKVSA-N
- GTPL9263
- SCHEMBL1205333
- GDC 0834;GDC0834
- ZINC59185874
- BDBM50388183
- AKOS030526267
- SB18925
- CS-3123
- Benzo(b)thiophene-2-carboxamide, N-(3-(6-((4-((2R)-1,4-dimethyl-3-oxo-2-piperazinyl)phenyl)amino)-4,5-dihydro-4-methyl-5-oxo-2-pyraz
- Gdc 0834
- RefChem:142767
- C33H36N6O3S
- orb1709625
- IVB43249
- EX-A10778
- MFCD22665722
- EBC-414066
- DA-63722
- HY-15427
- MS-30587
- F85030
- T11379
- }-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
- gdc-0834
Look up 2VL in the interactive SynDRA portal →